BCR-ABL1 formation seems to be an early event during CML pathogenesis which also governs numbers of downstream molecular deregulations responsible for cell proliferation, apoptosis resistance, survival, and cell-cycle progression, thus affecting the overall disease progression [29]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.